352 related articles for article (PubMed ID: 35083147)
1. Opportunities and Challenges of Nanoparticles in Digestive Tumours as Anti-Angiogenic Therapies.
Yang Z; Deng W; Zhang X; An Y; Liu Y; Yao H; Zhang Z
Front Oncol; 2021; 11():789330. PubMed ID: 35083147
[TBL] [Abstract][Full Text] [Related]
2. Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment.
Teleanu RI; Chircov C; Grumezescu AM; Teleanu DM
J Clin Med; 2019 Dec; 9(1):. PubMed ID: 31905724
[TBL] [Abstract][Full Text] [Related]
3. Novel anti-angiogenic therapies for malignant gliomas.
Norden AD; Drappatz J; Wen PY
Lancet Neurol; 2008 Dec; 7(12):1152-60. PubMed ID: 19007739
[TBL] [Abstract][Full Text] [Related]
4. Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models.
Bridgeman VL; Vermeulen PB; Foo S; Bilecz A; Daley F; Kostaras E; Nathan MR; Wan E; Frentzas S; Schweiger T; Hegedus B; Hoetzenecker K; Renyi-Vamos F; Kuczynski EA; Vasudev NS; Larkin J; Gore M; Dvorak HF; Paku S; Kerbel RS; Dome B; Reynolds AR
J Pathol; 2017 Feb; 241(3):362-374. PubMed ID: 27859259
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic application of anti-angiogenic nanomaterials in cancers.
Mukherjee S; Patra CR
Nanoscale; 2016 Jul; 8(25):12444-70. PubMed ID: 27067119
[TBL] [Abstract][Full Text] [Related]
6. Broad targeting of angiogenesis for cancer prevention and therapy.
Wang Z; Dabrosin C; Yin X; Fuster MM; Arreola A; Rathmell WK; Generali D; Nagaraju GP; El-Rayes B; Ribatti D; Chen YC; Honoki K; Fujii H; Georgakilas AG; Nowsheen S; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich B; Yang X; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Halicka D; Mohammed SI; Azmi AS; Bilsland A; Keith WN; Jensen LD
Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S224-S243. PubMed ID: 25600295
[TBL] [Abstract][Full Text] [Related]
7. κ Opioid receptor ligands regulate angiogenesis in development and in tumours.
Yamamizu K; Hamada Y; Narita M
Br J Pharmacol; 2015 Jan; 172(2):268-76. PubMed ID: 24417697
[TBL] [Abstract][Full Text] [Related]
8. Recent Development of Metal Nanoparticles for Angiogenesis Study and Their Therapeutic Applications.
Barui AK; Nethi SK; Haque S; Basuthakur P; Patra CR
ACS Appl Bio Mater; 2019 Dec; 2(12):5492-5511. PubMed ID: 35021545
[TBL] [Abstract][Full Text] [Related]
9. Potential of natural flavonoids to target breast cancer angiogenesis (review).
Wang Y; Huang M; Zhou X; Li H; Ma X; Sun C
Br J Pharmacol; 2023 Nov; ():. PubMed ID: 37940117
[TBL] [Abstract][Full Text] [Related]
10. Lysyl oxidase-like-2 promotes tumour angiogenesis and is a potential therapeutic target in angiogenic tumours.
Zaffryar-Eilot S; Marshall D; Voloshin T; Bar-Zion A; Spangler R; Kessler O; Ghermazien H; Brekhman V; Suss-Toby E; Adam D; Shaked Y; Smith V; Neufeld G
Carcinogenesis; 2013 Oct; 34(10):2370-9. PubMed ID: 23828904
[TBL] [Abstract][Full Text] [Related]
11. Research progress of exosomes in the angiogenesis of digestive system tumour.
Liu Y; Wu H; Sang Y; Chong W; Shang L; Li L
Discov Oncol; 2024 Feb; 15(1):33. PubMed ID: 38341827
[TBL] [Abstract][Full Text] [Related]
12. Nanomaterials for Antiangiogenic Therapies for Cancer: A Promising Tool for Personalized Medicine.
Alsaab HO; Al-Hibs AS; Alzhrani R; Alrabighi KK; Alqathama A; Alwithenani A; Almalki AH; Althobaiti YS
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562829
[TBL] [Abstract][Full Text] [Related]
13. Molecular regulation of tumor angiogenesis: mechanisms and therapeutic implications.
Harper J; Moses MA
EXS; 2006; (96):223-68. PubMed ID: 16383021
[TBL] [Abstract][Full Text] [Related]
14. Angiogenesis factors in gliomas: a new key to tumour therapy?
Mentlein R; Held-Feindt J
Naturwissenschaften; 2003 Sep; 90(9):385-94. PubMed ID: 14504780
[TBL] [Abstract][Full Text] [Related]
15. Vessel co-option and resistance to anti-angiogenic therapy.
Kuczynski EA; Reynolds AR
Angiogenesis; 2020 Feb; 23(1):55-74. PubMed ID: 31865479
[TBL] [Abstract][Full Text] [Related]
16. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis and anti-angiogenesis in neuroblastoma.
Ribatti D; Vacca A; Nico B; De Falco G; Giuseppe Montaldo P; Ponzoni M
Eur J Cancer; 2002 Apr; 38(6):750-7. PubMed ID: 11937307
[TBL] [Abstract][Full Text] [Related]
18. Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner.
Chauhan VP; Stylianopoulos T; Martin JD; Popović Z; Chen O; Kamoun WS; Bawendi MG; Fukumura D; Jain RK
Nat Nanotechnol; 2012 Apr; 7(6):383-8. PubMed ID: 22484912
[TBL] [Abstract][Full Text] [Related]
19. Tumour angiogenesis: a novel therapeutic target in patients with malignant disease.
O'Byrne KJ; Steward WP
Expert Opin Emerg Drugs; 2001 Apr; 6(1):155-74. PubMed ID: 15989502
[TBL] [Abstract][Full Text] [Related]
20. The role of angiogenesis in solid tumours: an overview.
Makrilia N; Lappa T; Xyla V; Nikolaidis I; Syrigos K
Eur J Intern Med; 2009 Nov; 20(7):663-71. PubMed ID: 19818284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
